Your browser doesn't support javascript.
loading
Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study.
Le Gal, Frédérique-Anne; Prevost-Blondel, Armelle; Lengagne, Renée; Bossus, Marc; Farace, Françoise; Chaboissier, Aude; Gras-Masse, Hélène; Engelhard, Victor H; Guillet, Jean-Gérard; Gahéry-Ségard, Hanne.
Affiliation
  • Le Gal FA; Laboratoire d'Immunologie des Pathologies Infectieuses et Tumorales, INSERM unité 445, I.C.G.M., Université R.Descartes, Hôpital Cochin, Paris, France.
Int J Cancer ; 98(2): 221-7, 2002 Mar 10.
Article in En | MEDLINE | ID: mdl-11857412
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / T-Lymphocytes, Cytotoxic / Cancer Vaccines / Epitopes / Neoplasm Proteins Limits: Animals Language: En Journal: Int J Cancer Year: 2002 Type: Article Affiliation country: France
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / T-Lymphocytes, Cytotoxic / Cancer Vaccines / Epitopes / Neoplasm Proteins Limits: Animals Language: En Journal: Int J Cancer Year: 2002 Type: Article Affiliation country: France